RxDoctor Payments Data

Kayla Deblauw, DPM

Foot & Ankle Surgery · Templeton, CANPI 1598389389

Payments from drug & device makers

$14,310in general payments, 2019–2025

Across 109 payments — averaging $131.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elite Orthopedics, LLC$8K
  • Stryker$5K
  • Arthrex$597
  • Cornerstone Medical Associates, Inc.$547
  • Johnson & Johnson$168
  • Bone Support Inc.$106
  • plus $410 from 9 others

What the payments were for

  • Travel & lodging$2,99321%
  • Food & beverage$3,65926%
  • Education$7,65854%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elite Orthopedics, LLC16$7,792
Stryker57$4,689
Arthrex5$597
Cornerstone Medical Associates, Inc.6$547
Johnson & Johnson2$168
Bone Support Inc.3$106
Bioventus LLC4$102
Organogenesis Inc.4$86
Electronic Waveform Lab, Inc.3$52
Mimedx Group, Inc.3$46
Smith+Nephew2$41
Medline Industries LP1$29
Paragon 28, Inc.1$19
KCI USA, Inc.1$17
Melinta Therapeutics, LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,310 in reported general payments places this provider in the 85th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$128,508
Medicare patients
340
Services billed
1,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil26$247
Terbinafine Hcl13$136
Meloxicam34$49

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Templeton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →